Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and pyrazolopyridine

2-chloro-n(6)cyclopentyladenosine has been researched along with pyrazolopyridine in 1 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)
Studies
(pyrazolopyridine)
Trials
(pyrazolopyridine)
Recent Studies (post-2010) (pyrazolopyridine)
252043104059

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akahane, A; Butcher, SP; Finlayson, K; Ito, H; Maemoto, T; Olverman, HJ1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and pyrazolopyridine

ArticleYear
Pyrazolopyridine derivatives act as competitive antagonists of brain adenosine A1 receptors: [35S]GTPgammaS binding studies.
    European journal of pharmacology, 1999, Jan-22, Volume: 365, Issue:2-3

    Topics: Adenosine; Animals; Binding, Competitive; Cerebral Cortex; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Male; Protein Binding; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1

1999